Education
About Us
Working with TipRanks
Follow Us
Bon Natural Life (BON)
NASDAQ:BON
BON Stock Chart & Stats
$1.70
-$0.04(-2.34%)
At close: 4:00 PM EST
$1.70
-$0.04(-2.34%)
Day’s Range― - ―
52-Week Range$1.14 - $5.06
Previous Close$1.67
Volume111.86K
Average Volume (3M)2.24M
Market Cap
$11.62M
Enterprise Value$14.76M
Total Cash (Recent Filing)$6.27M
Total Debt (Recent Filing)$12.32M
Price to Earnings (P/E)―
Beta1.84
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding6,086,971
10 Day Avg. Volume115,576
30 Day Avg. Volume2,242,045
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)0.09
Price to Sales (P/S)0.29
P/FCF Ratio-1.27
Enterprise Value/Market Cap1.27
Enterprise Value/Revenue0.79
Enterprise Value/Gross Profit3.81
Enterprise Value/Ebitda673.25
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Balance-sheet Cushion And Low LeverageGrowing equity and a relatively low debt-to-equity ratio provide a structural balance-sheet buffer that supports operations and potential capital needs while the business repairs profitability. This reduces near-term solvency risk and gives management flexibility for financing or strategic investments over months.
AI-driven Biomanufacturing Partnership And Joint LabA multi-year cooperation and an on-site joint lab signal a durable strategic shift toward AI-enhanced biomanufacturing. That can structurally improve ingredient quality, scale and cost efficiency, strengthening supply reliability and competitive differentiation in natural active ingredients over the medium term.
New CTO With Technical Depth And Multi-year ContractHiring a technically strong CTO on a multi-year contract can stabilize R&D leadership and accelerate product and process innovation. Sustained R&D capability supports longer-term pipeline development and execution of the company’s biomanufacturing and extraction strategies, aiding structural competitiveness.
Bears Say
Persistent Negative Free Cash FlowOngoing free cash flow deficits and extremely thin operating cash generation indicate structural cash burn that forces repeated external funding or asset drawdown. Over months this constrains capital allocation, limits reinvestment in growth or R&D, and raises refinancing and liquidity risk if profitability doesn't recover.
Revenue Decline And Margin CompressionDeclining sales and sharp margin erosion suggest weakening pricing power or rising input costs. A structural profit swing to loss undermines ability to cover fixed costs and fund growth internally, making recovery dependent on sustainable revenue restoration or durable margin improvement over several quarters.
Concentrated Leadership / Governance RiskConcentrated leadership and familial appointments raise governance and oversight concerns that can affect strategic objectivity, external partner confidence, and succession planning. Over the medium term this may limit access to certain partnerships or capital and complicate independent decision-making.
Bon Natural Life News
BON FAQ
What was Bon Natural Life’s price range in the past 12 months?
Bon Natural Life lowest stock price was $1.14 and its highest was $5.06 in the past 12 months.
What is Bon Natural Life’s market cap?
Bon Natural Life’s market cap is $11.62M.
When is Bon Natural Life’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Bon Natural Life’s earnings last quarter?
Currently, no data Available
Is Bon Natural Life overvalued?
According to Wall Street analysts Bon Natural Life’s price is currently Overvalued.
Does Bon Natural Life pay dividends?
Bon Natural Life does not currently pay dividends.
What is Bon Natural Life’s EPS estimate?
Bon Natural Life’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Bon Natural Life have?
Bon Natural Life has 6,086,971 shares outstanding.
What happened to Bon Natural Life’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Bon Natural Life?
Currently, no hedge funds are holding shares in BON
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Bon Natural Life
Bon Natural Life Limited, together with its subsidiaries, engages in the research and development, manufacture, and sale of functional active ingredients extracted from natural herb plants in the People's Republic of China and internationally. The company provides personal care ingredients, such as plant extracted fragrance compounds to perfume and fragrance manufacturers; natural health supplements comprising powder drinks and bioactive food ingredient products primarily used as food additives; and nutritional supplements. Its products are principally used by manufacturer customers in the functional food, personal care, cosmetic, and pharmaceutical industries. The company was founded in 2006 and is headquartered in Grand Cayman, the Cayman Islands.
Technical Analysis
Planet Green Holdings
―
Natural Alternatives International
―
Farmmi
―
Laird Superfood
―
Healthy Choice Wellness Corp. Class A
―